Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › GA › Duluth › NPI 1467092700
Lab

Qitek Labs LLC

Qitek Labs LLC was paid $4K by Medicaid between Oct 2020 and Mar 2021, across 2 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 63% of everything it billed.

33Billing provider infoQITEK LABS LLC
DULUTH, GA 30096
33aNPI1467092700assigned 01/15/2020
28Total paid$4K
24GClaims699
24DCodes billed2
24AFirst – last monthOct 2020 – Mar 2021
Compared with peers

Next to other Clinical Medical Laboratory providers in Georgia

Rank by total paid#54 of 66
Median peer was paid$178K
This provider vs. median0.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500$1.0K$1.5K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020565$3K
2021134$1K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 63% 354 309 $2K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 37% 345 298 $1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHUSK, ZACHARY (CEO)
Same official

Other billing entities under HUSK, ZACHARY

Full network →
ProviderLocationPaid
Qitek Labs of Oklahoma LLCOklahoma City, OK$10K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.